Project Grant HT94252310502
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33620, USA
Similar Awards
The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...
The Department of Defense's Defense Health Agency awarded a $1,158,179.00 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to deliver a sustained therapeutic protein cocktail delivery system to prevent vision loss after ocular trauma. The project aims to develop innovative treatments for military service members and veterans by conducting basic, translational, and clinical research. As a sub-award under this grant, the...
The Schepens Eye Research Institute, Inc. was awarded a $1,475,676 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to develop concomitant topical treatments for pain and inflammation resulting from ocular injuries. The Military Medical Research and Development program supports biomedical research that transforms military and public health...
This $1,622,955 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research and development of a novel therapeutic agent called LACRIPEP for corneal wound healing and ocular surface homeostasis. The grant was awarded on September 15, 2024 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit research organization, with a performance period ending on September 14,...
The Defense Health Agency awarded Duke University a $1,086,934 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop a compact, autoaligning multimodality eye imager to diagnose traumatic eye injuries. The award period runs from August 15, 2024 to August 14, 2027. Through this federal grant, Duke University will conduct research and development to create an advanced medical device that can accurately assess and diagnose traumatic eye conditions,...
This $1,473,430 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research on pluripotent stem cell-derived corneal endothelial cells for the treatment of combat laser-induced corneal edema and vision restoration. Spanning from September 1, 2024 to August 31, 2027, this award will enable Johns Hopkins to conduct innovative biomedical research to develop new treatments for military...
The Department of the Army Medical Command awarded a $1,428,860 Project Grant to The Schepens Eye Research Institute, Inc. of Boston, MA under the Military Medical Research and Development program (CFDA 12.420) to investigate the safety and efficacy of supersaturated oxygen emulsion (SSOE) as a novel topical treatment for open globe injury. The three-year award beginning September 30, 2022 will support animal research using mice to test SSOE and controls supplied by sub-awardee Coruna Medical...
The University of Connecticut Health Center (UCHC) received a $1,182,528 Project Grant award from the Defense Health Agency to develop a multifunctional bandage lens and bioadhesive for the treatment of corneal wounds. This award, which runs from September 1, 2023 to August 31, 2026, is funded under the Military Medical Research and Development program (CFDA 12.420). The grant supports UCHC's research to transform health care for Service Members and the American public through innovative and...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) provides $391,743.00 to Oregon Health & Science University (OHSU) to develop a compact, high-resolution, 3D optical imager for anterior eye injury and disease. The award term runs from October 1, 2024 to September 30, 2026. This research project aims to transform healthcare for military service members and the broader public by...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,477,500 Project Grant to The Schepens Eye Research Institute, Inc., a non-profit organization affiliated with Harvard Medical School and Massachusetts Eye and Ear. The 3-year grant, awarded on September 1, 2023, will fund research on "Topical Calcitonin Gene-Related Peptide for Corneal Injury Prevention and Regeneration." The Schepens Eye Research Institute, which has...